COONasdaqOphthalmic GoodsFiscal year ends October 31
COOPER COMPANIES, INC.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$58.16+0.22 (+0.38%)
Close on Oct 19, 2026
- Market cap
- $11.25B
- P/E (TTM)
- 19.8
- Dividend yield
- –
COOPER COMPANIES, INC. revenue by segment
By business segment
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CooperVision | $2.85B | $2.85B | $2.79B | $2.74B | – | – | – | – | – | – | – | – | 67.2% | – |
| Coopervision Segment | $2.85B | $2.85B | $2.79B | $2.74B | $2.71B | $2.67B | $2.63B | $2.61B | $2.56B | $2.51B | $2.46B | $2.42B | 67.2% | +5.0% |
| CooperSurgical | $1.39B | $1.38B | $1.36B | $1.35B | – | – | – | – | – | – | – | – | 32.8% | – |
| Coopersurgical Segment | $1.39B | $1.38B | $1.36B | $1.35B | $1.34B | $1.32B | $1.29B | $1.29B | $1.25B | $1.22B | $1.20B | $1.17B | 32.8% | +4.2% |
| Operating income | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CooperVision | $788.00M | $785.10M | $755.90M | $729.60M | – | – | – | – | – | – | – | – | – |
| CooperSurgical | -$153.40M | -$198.70M | $50.00M | $43.40M | – | – | – | – | – | – | – | – | – |
By product or service
By region
| Revenue | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $2.11B | $2.10B | $2.07B | $2.05B | $2.03B | $2.03B | $1.99B | $1.97B | $1.93B | $1.88B | $1.85B | $1.81B | 49.7% | +3.7% |
| Europe | $1.36B | $1.34B | $1.29B | $1.25B | $1.23B | $1.18B | $1.17B | $1.16B | $1.11B | $1.10B | $1.07B | $1.04B | 32.0% | +10.4% |
From the segment and revenue-disaggregation notes of Cooper Companies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.